Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI
- PMID: 34830567
- PMCID: PMC8618011
- DOI: 10.3390/jcm10225285
Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI
Abstract
Acute kidney injury (AKI) is common after cardiac surgery. To date, there are no specific pharmacological therapies. In this review, we summarise the existing evidence for prevention and management of cardiac surgery-associated AKI and outline areas for future research. Preoperatively, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers should be withheld and nephrotoxins should be avoided to reduce the risk. Intraoperative strategies include goal-directed therapy with individualised blood pressure management and administration of balanced fluids, the use of circuits with biocompatible coatings, application of minimally invasive extracorporeal circulation, and lung protective ventilation. Postoperative management should be in accordance with current KDIGO AKI recommendations.
Keywords: acute kidney injury (AKI); cardiac surgery; cardiac surgery associated AKI; cardiovascular; management; prevention; renal.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Nadim M.K., Forni L.G., Bihorac A., Hobson C., Koyner J.L., Shaw A., Arnaoutakis G.J., Ding X., Engelman D.T., Gasparovic H., et al. Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J. Am. Heart Assoc. 2018;7:e008834. doi: 10.1161/JAHA.118.008834. - DOI - PMC - PubMed
-
- Ostermann M., Cerdá J. The Burden of Acute Kidney Injury and Related Financial Issues. Contrib. Nephrol. 2018;193:100–112. - PubMed
LinkOut - more resources
Full Text Sources